Biotricity achieves improved margins, revenue growth, and reduced expenses, signaling positive performance
From GlobeNewswire: 2024-11-15 08:15:00
Biotricity Inc. achieved positive cash flow in September on a current operating basis, with Q2-FY25 revenue growing by 13% YOY to $3.3 million. Gross margins met management expectations at 75.3%, up from 69.1% last year. Recurring Technology Fee revenue comprised 94% of total revenue with a 79% gross profit percentage. The company reduced SG&A to $2.25 million, down 35.5% YOY. Biotricity continues to drive revenues and efficiencies, hosting its Q2 Fiscal Year 2025 Financial Results Call on November 15th at 4:30 p.m. ET. The company’s strong customer retention track record and focus on hospital networks have led to significant growth.
Read more at GlobeNewswire: Biotricity Achieves Improved Margins and Efficiencies, and